AIIMS Yoga Trial Cuts Alzheimer’s Biomarkers In 12 Weeks
A 12-week AIIMS New Delhi yoga trial in Alzheimer’s patients reported sharp drops in amyloid-beta-40, phosphorylated tau and inflammation markers, plus rising BDNF — extending earlier UCLA findings.